IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login
Users Online :50215
Small font sizeDefault font sizeIncrease font size
About Editorial Board Ahead of print Current Issue Archive Search Instructions Announcement Etcetera Contact Advertise
Navigate Here
  »   My Preferences 
  »   Manuscript submission
  »   Back To Article

» Article Access Statistics 

Year : 2021 | Volume:  53 | Issue Number:  3 | Page:  229-233

DRUG WATCH

The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
Chacko Jithin, Dhandapani Shankar, Jahagiridhar Vidhya, Swaminathan Krishnan

Number of times this article was viewed 2186
Number of times this article has been printed  from the site 166
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow